Compare · BOWN vs HLN
BOWN vs HLN
Side-by-side comparison of Bowen Acquisition Corp (BOWN) and Haleon plc (HLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BOWN and HLN operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- HLN carries a market cap of $45.33B.
- HLN has hit the wire 15 times in the past 4 weeks while BOWN has been quiet.
- HLN has more recent analyst coverage (19 ratings vs 0 for BOWN).
- Company
- Bowen Acquisition Corp
- Haleon plc
- Price
- $9.99+15.49%
- $10.18-0.05%
- Market cap
- -
- $45.33B
- 1M return
- -
- -0.88%
- 1Y return
- -
- +5.71%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NASDAQ
- NYSE
- IPO
- 2023
- 2022
- News (4w)
- 0
- 15
- Recent ratings
- 0
- 19
Haleon plc
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.
Latest BOWN
- SEC Form NT 10-Q filed by Bowen Acquisition Corp
- SEC Form PRE 14A filed by Bowen Acquisition Corp
- Bowen Acquisition Corp filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 10-Q filed by Bowen Acquisition Corp
- SEC Form NT 10-Q filed by Bowen Acquisition Corp
- Amendment: SEC Form SCHEDULE 13G/A filed by Bowen Acquisition Corp
- Bowen Acquisition Corp filed SEC Form 8-K: Financial Statements and Exhibits
- Bowen Acquisition Corp Receives NASDAQ Delisting Notification for Failure to Comply with Listing Requirements
- Nasdaq Halts Bowen Acquisition Corp.
- Bowen Acquisition Corp filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Latest HLN
- SEC Form CERT filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes
- SEC Form 6-K filed by Haleon plc
- Centrum Reframes Healthy Aging as a Proactive Practice for Adults 35 and Beyond
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc